PharmaCyte Biotech
PMCB
PMCB
28 hedge funds and large institutions have $2.02M invested in PharmaCyte Biotech in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $2.32M → $2.02M (-$296K)
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$54.4K | |
| 2 | +$54K | |
| 3 | +$34.9K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26.7K |
| 5 |
Renaissance Technologies
New York
|
+$9.21K |
Top Sellers
| 1 | -$46.4K | |
| 2 | -$20.3K | |
| 3 | -$15.2K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.45K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.29K |